Business article - June 16, 2026
How the Middle East conflict is affecting the life science industry
NLS asked Azza Chammem, Associate Director at Scope Ratings, a European credit rating agency, how the current conflict in the Middle East has affected the life science industry and what the future effects might be.
Business article - April 21, 2026
New Finnish deep-tech startup launched
VTT-originated startup Proteins.1 aims to bring PCR-like amplification and simplicity to omics.
Business article - April 20, 2026
White paper: Systemic barriers preventing women from reaching leadership roles
The Nordic life science sector is losing highly qualified female talent in top leadership positions, according to a new white paper published by Women in Life Science Denmark (WiLD), WiLD Norway, and VILDA Sweden.
Business article - April 20, 2026
New report: State of Nordic Women-Founded Startups 2025
The Even Founders report has tracked 219 Nordic companies (co-)founded by women that raised a combined EUR 707 million in 2025, underscoring both the scale of the opportunity and the cost of continued underinvestment.
Business article - April 7, 2026
Zealand Pharma establishes US Research Hub in Cambridge
The new research hub in Cambridge, Massachusetts, in the greater Boston area, will serve as Zealand Pharma’s primary US address and is expected to be operational from September 2026.
Business article - March 30, 2026
Diamyd reports negative interim Phase 3 results
Diamyd Medical have announced the completion of a pre-specified interim efficacy analysis on C-peptide in the ongoing Phase 3 DIAGNODE-3 trial evaluating retogatein (rhGAD65) in individuals with recent-onset Stage 3 type 1 diabetes carrying the HLA DR3-DQ2 haplotype. The interim analysis that included 174 out of 321 study participants did not demonstrate statistical significance on […]
